Ambulatory Blood Pressure Monitoring

William White

Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Lp(a): When to Measure it and What to Do About it

Collaborative CME and Research Network

M. O'Donoghue

Should Colchicine Become Standard Therapy for CAD?

Collaborative CME and Research Network

P. Ridker

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Scripps Health

M. Budoff

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Recent Cholesterol Guidelines and Integration into Clinical Practice

Vasculearn Network

J. Plutzky, L. Braun, J. Ross

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

Review of Coronary Artery Calcium Testing for Primary Care

Dr. Catherine P. Benziger

C. Benziger

Cardiovascular Disease and Osteoporosis

Olaitan Adeyoola

O. Adeyoola

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

ACC 2025 Insights: Diabetes and Plaque Stabilization in Patients Tre…

ACC 2025 Insights

K. Yasumura

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

Cardiovascular Disease Risk Stratification and Medication Allocation…

MonteHeart Imaging & Clinical Lectures

S. Whelton

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald